Skip to content

Medical-device intelligence

Viewray Incorporated: FDA clearances and recalls

Research Viewray Incorporated in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

6 clearance records and 6 recall records in the covered releases, across 1 source company names and 2 product codes. Dated history runs from Jan 12, 2011 to Dec 14, 2021.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

12 matching records
Device / recordCompany in FDA recordSourceSource date
MRIdian Linac SystemK212958 · IYEViewray, Incorporated510(k)Dec 14, 2021FDA decision date
MRIdian Linac SystemK181989 · IYEViewray, Incorporated510(k)Feb 20, 2019FDA decision date
MRIdian Linac System with 138-leaf CollimatorK170751 · IYEViewray, Incorporated510(k)Jun 7, 2017FDA decision date
The ViewRay (MRIdian) Linac SystemK162393 · IYEViewray, Incorporated510(k)Feb 24, 2017FDA decision date
MRIdian ViewRay Radiation Therapy System, ViewRay Treatment Planning and Delivery System (also known as the MRIdian System) is indicated for ster…Z-1309-2016 · IYEViewray IncorporatedRecallMar 31, 2016FDA classification date
MRIdian ViewRay Radiation Therapy System, VIEWRAY Inc.Z-0806-2016 · IYEViewray IncorporatedRecallFeb 12, 2016FDA classification date
MRIdian ViewRay Radiation Therapy System, ViewRay Is indicated for stereotactic radiosurgery and precision radiotherapy for lesions, tumors, an…Z-0115-2016 · IYEViewray IncorporatedRecallOct 9, 2015FDA classification date
Patient Handling System (Motion Control Software), Product Usage: Indicated for stereotactic radiosurgery and precision radiotherapy for lesion…Z-2085-2015 · IYEViewray IncorporatedRecallJul 16, 2015FDA classification date
Treatment Planning and Delivery System Software version 3.6. ViewRay. Indicated for stereotactic radiosurgery and precision radiotherapy for le…Z-1954-2015 · IYEViewray IncorporatedRecallJul 2, 2015FDA classification date
ViewRay System, Radiation Therapy SystemZ-1580-2015 · IYEViewray IncorporatedRecallMay 5, 2015FDA classification date
VIEWRAY SYSTEMK111862 · IYEViewray, Incorporated510(k)May 22, 2012FDA decision date
VIEWRAY TREATMENT PLANNING AND DELIVERY SYSTEMK102915 · MUJViewray, Incorporated510(k)Jan 12, 2011FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗